---
title: "The Readiness Paradox: Why Audit Success No Longer Predicts Clinical-Stage Performance in Biotech"
canonical: "https://www.qualio.com/resources/readiness-paradox-biotech"
updatedDate: "2026-11-15T15:08:29.000Z"
description: "Growth-stage biotech companies routinely pass GLP audits and regulatory inspections, yet still experience submission delays, rising consultant costs, and evidence gaps at the moments that matter most."
---

## The Readiness Paradox: Why Audit Success No Longer Predicts Clinical-Stage Performance in Biotech
